Trade Summary

6 days ago, Duato Joaquin, serving as CEO and Chairman of the Board at JOHNSON & JOHNSON (JNJ), sold 48,480 shares at $258.15 per share, for a total transaction value of $12,515,010.09. Following this transaction, Duato Joaquin now holds 275,967 shares of JNJ.

This sale represents a 14.94% decrease in Duato Joaquin's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, August 5, 2026 and publicly disclosed via SEC Form 4 filing on Friday, August 7, 2026 at 5:50 PM ET, 2 days after the trade was made.

JOHNSON & JOHNSON operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - GENERAL industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.